Latest Mergers And Acquisitions News

Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Norfolk Metals has completed Phase #1 of its maiden drilling campaign at the Carmen Copper Project in Chile, confirming significant higher-grade copper sulphide mineralisation open at depth. The company also secured firm commitments for a $2.1 million placement to fund ongoing exploration.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

Polymetals Resources has resumed operations at its Endeavor Mine following a tragic incident, completing first concentrate shipments and securing $34.4 million in new capital to support exploration and ramp-up.

Stellar Resources has reported significant progress in its December quarter, advancing the Heemskirk Tin Project through robust drilling results and metallurgical studies, supported by a $9.5 million capital raise.

Terra Metals has confirmed a new platinum group metal-copper-nickel sulfide discovery at the SW5 target within its Dante Project, revealing a significant expansion of mineralisation beyond existing resources. This second discovery complements the earlier SW6 find and underscores the potential scale of the magmatic sulfide system in Western Australia.

HighCom Limited reveals a challenging first half of FY26 with losses linked to the US Government shutdown but signals a confident turnaround in the second half driven by diversification and operational improvements.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Predictive Discovery has secured a crucial court approval for its acquisition of Robex Resources, paving the way for the deal to close in early 2026 pending final regulatory consents.

Robex Resources has received final court approval for its merger with Predictive Discovery, setting the stage for completion in early 2026 pending regulatory consents. This move could reshape the future of Robex’s West African gold projects.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.